Incidence and molecular characteristics of deficient mismatch repair conditions across nine different tumors and identification of germline variants involved in Lynch-like syndrome
Background Based on molecular characteristics, deficient DNA mismatch repair (dMMR) solid tumors are largely divided into three categories: somatically MLH1 -hypermethylated tumors, Lynch syndrome (LS)-associated tumors, and Lynch-like syndrome (LLS)-associated tumors. The incidence of each of these...
Gespeichert in:
Veröffentlicht in: | International journal of clinical oncology 2024-07, Vol.29 (7), p.953-963 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 963 |
---|---|
container_issue | 7 |
container_start_page | 953 |
container_title | International journal of clinical oncology |
container_volume | 29 |
creator | Ito, Tetsuya Yamaguchi, Tatsuro Kumamoto, Kensuke Suzuki, Okihide Chika, Noriyasu Kawakami, Satoru Nagai, Tomonori Igawa, Tsukasa Fujiyoshi, Kenji Akagi, Yoshito Arai, Tomio Akagi, Kiwamu Eguchi, Hidetaka Okazaki, Yasushi Ishida, Hideyuki |
description | Background
Based on molecular characteristics, deficient DNA mismatch repair (dMMR) solid tumors are largely divided into three categories: somatically
MLH1
-hypermethylated tumors, Lynch syndrome (LS)-associated tumors, and Lynch-like syndrome (LLS)-associated tumors. The incidence of each of these conditions and the corresponding pathogenic genes related to LLS remain elusive.
Methods
We identified dMMR tumors in 3609 tumors from 9 different solid organs, including colorectal cancer, gastric cancer, small-bowel cancer, endometrial cancer, ovarian cancer, upper urinary tract cancer, urinary bladder cancer, prostate cancer, and sebaceous tumor, and comprehensively summarized the characterization of dMMR tumors. Characterization of dMMR tumors were performed as loss of at least one of MMR proteins (MLH1, MSH2, MSH6, and PMS2), by immunohistochemistry, followed by
MLH1
promotor methylation analysis and genetic testing for MMR genes where appropriate. Somatic variant analysis of MMR genes and whole exome sequencing (WES) were performed in patients with LLS.
Results
In total, the incidence of dMMR tumors was 5.9% (24/3609). The incidence of dMMR tumors and the proportion of the three categorized dMMR tumors varied considerably with different tumor types. One to three likely pathogenic/pathogenic somatic MMR gene variants were detected in 15 out of the 16 available LLS tumors. One patient each from 12 patients who gave consent to WES demonstrated non-
MMR
germline variants affect function (
POLQ
or
BRCA1
).
Conclusions
Our data regarding the LS to LLS ratio would be useful for genetic counseling in patients who are suspected to have LS, though the genetic backgrounds for the pathogenesis of LLS need further investigation. |
doi_str_mv | 10.1007/s10147-024-02518-y |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11196295</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3071639273</sourcerecordid><originalsourceid>FETCH-LOGICAL-c426t-d03d8640e281f798a9a1abcb5dda719c800600185c7ca2cc16552dade606e9233</originalsourceid><addsrcrecordid>eNp9ksuO1DAQRSMEYh7wAyyQJTZsAraT2MkKoREMI7XEBtZWtV2Z9pDYjZ20lP_iA6l0D8NjwcKypTp16-FbFC8EfyM412-z4KLWJZc1nUa05fKoOBd1pUuttXxM76oWZadkc1Zc5HzHudCqkU-Ls6pVopGtOi9-3ATrHQaLDIJjYxzQzgMkZneQwE6YfJ68zSz2zGHvrccwsdHnESa7Ywn34AmOwfnJx5AZ2BRzZsEHZM73PaY1YZrHmPKxxFpt8qQEa8Kqe4tpHFb-AMlDmDLz4RCHAxIc2GYJdlcO_huyvASX4ojPiic9DBmf39-XxdePH75cfSo3n69vrt5vSltLNZWOV65VNUfZil53LXQgYGu3jXOgRWdbzhXtpG2stiCtFapppAOHiivsZFVdFu9Ouvt5O6Kz1HiCweyTHyEtJoI3f0eC35nbeDBCCFp715DC63uFFL_PmCdDq7M4DBAwztlUvGpralYoQl_9g97FOQWajyhNQCf12pI8Ucc1J-wfuhHcrK4wJ1cYcoU5usIslPTyzzkeUn7ZgIDqBGQKBfqP37X_I_sTO23JWA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3071639273</pqid></control><display><type>article</type><title>Incidence and molecular characteristics of deficient mismatch repair conditions across nine different tumors and identification of germline variants involved in Lynch-like syndrome</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Ito, Tetsuya ; Yamaguchi, Tatsuro ; Kumamoto, Kensuke ; Suzuki, Okihide ; Chika, Noriyasu ; Kawakami, Satoru ; Nagai, Tomonori ; Igawa, Tsukasa ; Fujiyoshi, Kenji ; Akagi, Yoshito ; Arai, Tomio ; Akagi, Kiwamu ; Eguchi, Hidetaka ; Okazaki, Yasushi ; Ishida, Hideyuki</creator><creatorcontrib>Ito, Tetsuya ; Yamaguchi, Tatsuro ; Kumamoto, Kensuke ; Suzuki, Okihide ; Chika, Noriyasu ; Kawakami, Satoru ; Nagai, Tomonori ; Igawa, Tsukasa ; Fujiyoshi, Kenji ; Akagi, Yoshito ; Arai, Tomio ; Akagi, Kiwamu ; Eguchi, Hidetaka ; Okazaki, Yasushi ; Ishida, Hideyuki</creatorcontrib><description>Background
Based on molecular characteristics, deficient DNA mismatch repair (dMMR) solid tumors are largely divided into three categories: somatically
MLH1
-hypermethylated tumors, Lynch syndrome (LS)-associated tumors, and Lynch-like syndrome (LLS)-associated tumors. The incidence of each of these conditions and the corresponding pathogenic genes related to LLS remain elusive.
Methods
We identified dMMR tumors in 3609 tumors from 9 different solid organs, including colorectal cancer, gastric cancer, small-bowel cancer, endometrial cancer, ovarian cancer, upper urinary tract cancer, urinary bladder cancer, prostate cancer, and sebaceous tumor, and comprehensively summarized the characterization of dMMR tumors. Characterization of dMMR tumors were performed as loss of at least one of MMR proteins (MLH1, MSH2, MSH6, and PMS2), by immunohistochemistry, followed by
MLH1
promotor methylation analysis and genetic testing for MMR genes where appropriate. Somatic variant analysis of MMR genes and whole exome sequencing (WES) were performed in patients with LLS.
Results
In total, the incidence of dMMR tumors was 5.9% (24/3609). The incidence of dMMR tumors and the proportion of the three categorized dMMR tumors varied considerably with different tumor types. One to three likely pathogenic/pathogenic somatic MMR gene variants were detected in 15 out of the 16 available LLS tumors. One patient each from 12 patients who gave consent to WES demonstrated non-
MMR
germline variants affect function (
POLQ
or
BRCA1
).
Conclusions
Our data regarding the LS to LLS ratio would be useful for genetic counseling in patients who are suspected to have LS, though the genetic backgrounds for the pathogenesis of LLS need further investigation.</description><identifier>ISSN: 1341-9625</identifier><identifier>ISSN: 1437-7772</identifier><identifier>EISSN: 1437-7772</identifier><identifier>DOI: 10.1007/s10147-024-02518-y</identifier><identifier>PMID: 38615286</identifier><language>eng</language><publisher>Singapore: Springer Nature Singapore</publisher><subject>Adult ; Aged ; Bladder cancer ; BRCA1 protein ; Cancer ; Cancer Research ; Colorectal cancer ; Colorectal carcinoma ; Colorectal Neoplasms, Hereditary Nonpolyposis - genetics ; Colorectal Neoplasms, Hereditary Nonpolyposis - pathology ; DNA Methylation ; DNA Mismatch Repair - genetics ; DNA repair ; Endometrial cancer ; Exome Sequencing ; Female ; Gastric cancer ; Genetic analysis ; Genetic counseling ; Genetic disorders ; Genetic screening ; Germ-Line Mutation ; Humans ; Immunohistochemistry ; Incidence ; Male ; Medicine ; Medicine & Public Health ; Middle Aged ; Mismatch repair ; MLH1 protein ; MSH2 protein ; MSH6 protein ; MutL Protein Homolog 1 - genetics ; Oncology ; Original ; Original Article ; Ovarian cancer ; Prostate cancer ; Solid tumors ; Surgical Oncology ; Tumors ; Urinary bladder ; Urinary tract ; Uterine cancer ; Whole genome sequencing</subject><ispartof>International journal of clinical oncology, 2024-07, Vol.29 (7), p.953-963</ispartof><rights>The Author(s) 2024</rights><rights>2024. The Author(s).</rights><rights>The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c426t-d03d8640e281f798a9a1abcb5dda719c800600185c7ca2cc16552dade606e9233</cites><orcidid>0000-0002-1689-0963</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10147-024-02518-y$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10147-024-02518-y$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,27903,27904,41467,42536,51297</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38615286$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ito, Tetsuya</creatorcontrib><creatorcontrib>Yamaguchi, Tatsuro</creatorcontrib><creatorcontrib>Kumamoto, Kensuke</creatorcontrib><creatorcontrib>Suzuki, Okihide</creatorcontrib><creatorcontrib>Chika, Noriyasu</creatorcontrib><creatorcontrib>Kawakami, Satoru</creatorcontrib><creatorcontrib>Nagai, Tomonori</creatorcontrib><creatorcontrib>Igawa, Tsukasa</creatorcontrib><creatorcontrib>Fujiyoshi, Kenji</creatorcontrib><creatorcontrib>Akagi, Yoshito</creatorcontrib><creatorcontrib>Arai, Tomio</creatorcontrib><creatorcontrib>Akagi, Kiwamu</creatorcontrib><creatorcontrib>Eguchi, Hidetaka</creatorcontrib><creatorcontrib>Okazaki, Yasushi</creatorcontrib><creatorcontrib>Ishida, Hideyuki</creatorcontrib><title>Incidence and molecular characteristics of deficient mismatch repair conditions across nine different tumors and identification of germline variants involved in Lynch-like syndrome</title><title>International journal of clinical oncology</title><addtitle>Int J Clin Oncol</addtitle><addtitle>Int J Clin Oncol</addtitle><description>Background
Based on molecular characteristics, deficient DNA mismatch repair (dMMR) solid tumors are largely divided into three categories: somatically
MLH1
-hypermethylated tumors, Lynch syndrome (LS)-associated tumors, and Lynch-like syndrome (LLS)-associated tumors. The incidence of each of these conditions and the corresponding pathogenic genes related to LLS remain elusive.
Methods
We identified dMMR tumors in 3609 tumors from 9 different solid organs, including colorectal cancer, gastric cancer, small-bowel cancer, endometrial cancer, ovarian cancer, upper urinary tract cancer, urinary bladder cancer, prostate cancer, and sebaceous tumor, and comprehensively summarized the characterization of dMMR tumors. Characterization of dMMR tumors were performed as loss of at least one of MMR proteins (MLH1, MSH2, MSH6, and PMS2), by immunohistochemistry, followed by
MLH1
promotor methylation analysis and genetic testing for MMR genes where appropriate. Somatic variant analysis of MMR genes and whole exome sequencing (WES) were performed in patients with LLS.
Results
In total, the incidence of dMMR tumors was 5.9% (24/3609). The incidence of dMMR tumors and the proportion of the three categorized dMMR tumors varied considerably with different tumor types. One to three likely pathogenic/pathogenic somatic MMR gene variants were detected in 15 out of the 16 available LLS tumors. One patient each from 12 patients who gave consent to WES demonstrated non-
MMR
germline variants affect function (
POLQ
or
BRCA1
).
Conclusions
Our data regarding the LS to LLS ratio would be useful for genetic counseling in patients who are suspected to have LS, though the genetic backgrounds for the pathogenesis of LLS need further investigation.</description><subject>Adult</subject><subject>Aged</subject><subject>Bladder cancer</subject><subject>BRCA1 protein</subject><subject>Cancer</subject><subject>Cancer Research</subject><subject>Colorectal cancer</subject><subject>Colorectal carcinoma</subject><subject>Colorectal Neoplasms, Hereditary Nonpolyposis - genetics</subject><subject>Colorectal Neoplasms, Hereditary Nonpolyposis - pathology</subject><subject>DNA Methylation</subject><subject>DNA Mismatch Repair - genetics</subject><subject>DNA repair</subject><subject>Endometrial cancer</subject><subject>Exome Sequencing</subject><subject>Female</subject><subject>Gastric cancer</subject><subject>Genetic analysis</subject><subject>Genetic counseling</subject><subject>Genetic disorders</subject><subject>Genetic screening</subject><subject>Germ-Line Mutation</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Incidence</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Mismatch repair</subject><subject>MLH1 protein</subject><subject>MSH2 protein</subject><subject>MSH6 protein</subject><subject>MutL Protein Homolog 1 - genetics</subject><subject>Oncology</subject><subject>Original</subject><subject>Original Article</subject><subject>Ovarian cancer</subject><subject>Prostate cancer</subject><subject>Solid tumors</subject><subject>Surgical Oncology</subject><subject>Tumors</subject><subject>Urinary bladder</subject><subject>Urinary tract</subject><subject>Uterine cancer</subject><subject>Whole genome sequencing</subject><issn>1341-9625</issn><issn>1437-7772</issn><issn>1437-7772</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><recordid>eNp9ksuO1DAQRSMEYh7wAyyQJTZsAraT2MkKoREMI7XEBtZWtV2Z9pDYjZ20lP_iA6l0D8NjwcKypTp16-FbFC8EfyM412-z4KLWJZc1nUa05fKoOBd1pUuttXxM76oWZadkc1Zc5HzHudCqkU-Ls6pVopGtOi9-3ATrHQaLDIJjYxzQzgMkZneQwE6YfJ68zSz2zGHvrccwsdHnESa7Ywn34AmOwfnJx5AZ2BRzZsEHZM73PaY1YZrHmPKxxFpt8qQEa8Kqe4tpHFb-AMlDmDLz4RCHAxIc2GYJdlcO_huyvASX4ojPiic9DBmf39-XxdePH75cfSo3n69vrt5vSltLNZWOV65VNUfZil53LXQgYGu3jXOgRWdbzhXtpG2stiCtFapppAOHiivsZFVdFu9Ouvt5O6Kz1HiCweyTHyEtJoI3f0eC35nbeDBCCFp715DC63uFFL_PmCdDq7M4DBAwztlUvGpralYoQl_9g97FOQWajyhNQCf12pI8Ucc1J-wfuhHcrK4wJ1cYcoU5usIslPTyzzkeUn7ZgIDqBGQKBfqP37X_I_sTO23JWA</recordid><startdate>202407</startdate><enddate>202407</enddate><creator>Ito, Tetsuya</creator><creator>Yamaguchi, Tatsuro</creator><creator>Kumamoto, Kensuke</creator><creator>Suzuki, Okihide</creator><creator>Chika, Noriyasu</creator><creator>Kawakami, Satoru</creator><creator>Nagai, Tomonori</creator><creator>Igawa, Tsukasa</creator><creator>Fujiyoshi, Kenji</creator><creator>Akagi, Yoshito</creator><creator>Arai, Tomio</creator><creator>Akagi, Kiwamu</creator><creator>Eguchi, Hidetaka</creator><creator>Okazaki, Yasushi</creator><creator>Ishida, Hideyuki</creator><general>Springer Nature Singapore</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-1689-0963</orcidid></search><sort><creationdate>202407</creationdate><title>Incidence and molecular characteristics of deficient mismatch repair conditions across nine different tumors and identification of germline variants involved in Lynch-like syndrome</title><author>Ito, Tetsuya ; Yamaguchi, Tatsuro ; Kumamoto, Kensuke ; Suzuki, Okihide ; Chika, Noriyasu ; Kawakami, Satoru ; Nagai, Tomonori ; Igawa, Tsukasa ; Fujiyoshi, Kenji ; Akagi, Yoshito ; Arai, Tomio ; Akagi, Kiwamu ; Eguchi, Hidetaka ; Okazaki, Yasushi ; Ishida, Hideyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c426t-d03d8640e281f798a9a1abcb5dda719c800600185c7ca2cc16552dade606e9233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Bladder cancer</topic><topic>BRCA1 protein</topic><topic>Cancer</topic><topic>Cancer Research</topic><topic>Colorectal cancer</topic><topic>Colorectal carcinoma</topic><topic>Colorectal Neoplasms, Hereditary Nonpolyposis - genetics</topic><topic>Colorectal Neoplasms, Hereditary Nonpolyposis - pathology</topic><topic>DNA Methylation</topic><topic>DNA Mismatch Repair - genetics</topic><topic>DNA repair</topic><topic>Endometrial cancer</topic><topic>Exome Sequencing</topic><topic>Female</topic><topic>Gastric cancer</topic><topic>Genetic analysis</topic><topic>Genetic counseling</topic><topic>Genetic disorders</topic><topic>Genetic screening</topic><topic>Germ-Line Mutation</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Incidence</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Mismatch repair</topic><topic>MLH1 protein</topic><topic>MSH2 protein</topic><topic>MSH6 protein</topic><topic>MutL Protein Homolog 1 - genetics</topic><topic>Oncology</topic><topic>Original</topic><topic>Original Article</topic><topic>Ovarian cancer</topic><topic>Prostate cancer</topic><topic>Solid tumors</topic><topic>Surgical Oncology</topic><topic>Tumors</topic><topic>Urinary bladder</topic><topic>Urinary tract</topic><topic>Uterine cancer</topic><topic>Whole genome sequencing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ito, Tetsuya</creatorcontrib><creatorcontrib>Yamaguchi, Tatsuro</creatorcontrib><creatorcontrib>Kumamoto, Kensuke</creatorcontrib><creatorcontrib>Suzuki, Okihide</creatorcontrib><creatorcontrib>Chika, Noriyasu</creatorcontrib><creatorcontrib>Kawakami, Satoru</creatorcontrib><creatorcontrib>Nagai, Tomonori</creatorcontrib><creatorcontrib>Igawa, Tsukasa</creatorcontrib><creatorcontrib>Fujiyoshi, Kenji</creatorcontrib><creatorcontrib>Akagi, Yoshito</creatorcontrib><creatorcontrib>Arai, Tomio</creatorcontrib><creatorcontrib>Akagi, Kiwamu</creatorcontrib><creatorcontrib>Eguchi, Hidetaka</creatorcontrib><creatorcontrib>Okazaki, Yasushi</creatorcontrib><creatorcontrib>Ishida, Hideyuki</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ito, Tetsuya</au><au>Yamaguchi, Tatsuro</au><au>Kumamoto, Kensuke</au><au>Suzuki, Okihide</au><au>Chika, Noriyasu</au><au>Kawakami, Satoru</au><au>Nagai, Tomonori</au><au>Igawa, Tsukasa</au><au>Fujiyoshi, Kenji</au><au>Akagi, Yoshito</au><au>Arai, Tomio</au><au>Akagi, Kiwamu</au><au>Eguchi, Hidetaka</au><au>Okazaki, Yasushi</au><au>Ishida, Hideyuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Incidence and molecular characteristics of deficient mismatch repair conditions across nine different tumors and identification of germline variants involved in Lynch-like syndrome</atitle><jtitle>International journal of clinical oncology</jtitle><stitle>Int J Clin Oncol</stitle><addtitle>Int J Clin Oncol</addtitle><date>2024-07</date><risdate>2024</risdate><volume>29</volume><issue>7</issue><spage>953</spage><epage>963</epage><pages>953-963</pages><issn>1341-9625</issn><issn>1437-7772</issn><eissn>1437-7772</eissn><abstract>Background
Based on molecular characteristics, deficient DNA mismatch repair (dMMR) solid tumors are largely divided into three categories: somatically
MLH1
-hypermethylated tumors, Lynch syndrome (LS)-associated tumors, and Lynch-like syndrome (LLS)-associated tumors. The incidence of each of these conditions and the corresponding pathogenic genes related to LLS remain elusive.
Methods
We identified dMMR tumors in 3609 tumors from 9 different solid organs, including colorectal cancer, gastric cancer, small-bowel cancer, endometrial cancer, ovarian cancer, upper urinary tract cancer, urinary bladder cancer, prostate cancer, and sebaceous tumor, and comprehensively summarized the characterization of dMMR tumors. Characterization of dMMR tumors were performed as loss of at least one of MMR proteins (MLH1, MSH2, MSH6, and PMS2), by immunohistochemistry, followed by
MLH1
promotor methylation analysis and genetic testing for MMR genes where appropriate. Somatic variant analysis of MMR genes and whole exome sequencing (WES) were performed in patients with LLS.
Results
In total, the incidence of dMMR tumors was 5.9% (24/3609). The incidence of dMMR tumors and the proportion of the three categorized dMMR tumors varied considerably with different tumor types. One to three likely pathogenic/pathogenic somatic MMR gene variants were detected in 15 out of the 16 available LLS tumors. One patient each from 12 patients who gave consent to WES demonstrated non-
MMR
germline variants affect function (
POLQ
or
BRCA1
).
Conclusions
Our data regarding the LS to LLS ratio would be useful for genetic counseling in patients who are suspected to have LS, though the genetic backgrounds for the pathogenesis of LLS need further investigation.</abstract><cop>Singapore</cop><pub>Springer Nature Singapore</pub><pmid>38615286</pmid><doi>10.1007/s10147-024-02518-y</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-1689-0963</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1341-9625 |
ispartof | International journal of clinical oncology, 2024-07, Vol.29 (7), p.953-963 |
issn | 1341-9625 1437-7772 1437-7772 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11196295 |
source | MEDLINE; SpringerLink Journals |
subjects | Adult Aged Bladder cancer BRCA1 protein Cancer Cancer Research Colorectal cancer Colorectal carcinoma Colorectal Neoplasms, Hereditary Nonpolyposis - genetics Colorectal Neoplasms, Hereditary Nonpolyposis - pathology DNA Methylation DNA Mismatch Repair - genetics DNA repair Endometrial cancer Exome Sequencing Female Gastric cancer Genetic analysis Genetic counseling Genetic disorders Genetic screening Germ-Line Mutation Humans Immunohistochemistry Incidence Male Medicine Medicine & Public Health Middle Aged Mismatch repair MLH1 protein MSH2 protein MSH6 protein MutL Protein Homolog 1 - genetics Oncology Original Original Article Ovarian cancer Prostate cancer Solid tumors Surgical Oncology Tumors Urinary bladder Urinary tract Uterine cancer Whole genome sequencing |
title | Incidence and molecular characteristics of deficient mismatch repair conditions across nine different tumors and identification of germline variants involved in Lynch-like syndrome |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T10%3A21%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Incidence%20and%20molecular%20characteristics%20of%20deficient%20mismatch%20repair%20conditions%20across%20nine%20different%20tumors%20and%20identification%20of%20germline%20variants%20involved%20in%20Lynch-like%20syndrome&rft.jtitle=International%20journal%20of%20clinical%20oncology&rft.au=Ito,%20Tetsuya&rft.date=2024-07&rft.volume=29&rft.issue=7&rft.spage=953&rft.epage=963&rft.pages=953-963&rft.issn=1341-9625&rft.eissn=1437-7772&rft_id=info:doi/10.1007/s10147-024-02518-y&rft_dat=%3Cproquest_pubme%3E3071639273%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3071639273&rft_id=info:pmid/38615286&rfr_iscdi=true |